Sai Life Sciences
add_icon

Sai Life Sciences

880.00
+5.35
(0.61%)
Market Cap
₹18,413.94 Cr
PE Ratio
64.13
Volume
1,89,049.00
Day High - Low
₹882.00 - ₹868.05
52W High-Low
₹943.00 - ₹636.10
ann
There are 1 new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
18,413.94 Cr
EPS
8.83
PB Ratio
8.09
Book Value
107.99
EBITDA
442.40
Dividend Yield
0.00 %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
0.41
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Sai Life Sciences Allots 62,991 Equity Shares Under Employee Stock Option Plans3 days ago
Sai Life Sciences allotted 62,991 equity shares of Re. 1 each upon exercise of options under ESOP 2008 (17,991 shares at Rs. 188.90) and MESOP 2018 (45,000 shares at Rs. 127.30) on November 22, 2025. The allotment increases the company's total issued share capital to 210,234,752 shares, providing incentives to retain and reward employees while contributing to company growth.
negative
Joint Commissioner of Commercial Taxes issued an order demanding INR 20.85 crore in IGST, INR 13.75 crore in interest, and INR 2.08 crore in penalty from Sai Life Sciences for alleged non-payment of taxes on intermediary services from US subsidiary during July 2017 to March 2022. The company plans to appeal the order and expects no material financial impact, believing it will receive a favorable outcome at the tribunal level.
negative
Sai Life Sciences Limited has released the transcript of its earnings call for unaudited financial results for the quarter and half year ended September 30, 2025. The earnings call was held on November 7, 2025, and the transcript has been made available on the company's website and submitted to stock exchanges.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,804.90
#1 4,33,055.97
40.68
#1 54,729.00
9.71
#1 10,980
2.89
75.42
6,510.00
1,72,820.05
69.05
9,712.00
18.67
2,191
35.10
51.73
3,755.80
1,27,113.34
58.80
11,539.40
6.99
1,911
30.46
58.02
1,523.80
1,23,085.57
22.73
28,409.50
7.12
5,291
3.71
48.15
1,248.00
1,04,159.80
#1 18.15
33,741.20
16.73
5,725
-0.38
53.26
940.55
94,641.34
18.56
23,511.00
18.55
4,615
34.60
42.59
2,071.60
94,621.27
21.34
22,909.50
13.74
3,306
#1 72.75
63.49
2,258.90
93,238.02
52.05
12,744.20
#1 20.90
2,007
-21.05
39.74
1,227.40
71,287.59
20.70
32,345.60
9.43
3,484
3.81
65.66
5,773.00
69,024.87
28.29
13,458.30
3.70
2,216
10.98
63.75

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
15.86 %
Net Income Growth
105.43 %
Cash Flow Change
19.37 %
ROE
-5.89 %
ROCE
-1.49 %
EBITDA Margin (Avg.)
21.38 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
395
443
288
406
449
589
506
553
Expenses
287
315
254
293
320
422
376
392
EBITDA
108
128
34
112
129
167
131
161
Operating Profit %
25 %
28 %
9 %
26 %
27 %
27 %
24 %
27 %
Depreciation
31
31
31
36
34
38
38
40
Interest
23
21
21
21
23
11
12
9
Profit Before Tax
53
76
-18
55
72
119
81
112
Tax
13
20
-5
14
18
31
20
28
Net Profit
40
56
-14
42
54
88
61
84
EPS in ₹
2.19
31.00
-0.74
2.22
2.89
4.24
2.90
4.01

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
1,410
1,817
2,157
2,187
2,275
3,160
Fixed Assets
641
753
751
1,037
1,180
1,488
Current Assets
613
804
944
964
945
1,505
Capital Work in Progress
91
194
410
151
107
125
Investments
0
0
0
2
2
2
Other Assets
679
870
997
997
987
1,545
Total Liabilities
1,410
1,817
2,157
2,187
2,275
3,160
Current Liabilities
467
599
713
759
740
733
Non Current Liabilities
149
356
565
540
560
299
Total Equity
794
863
879
888
975
2,128
Reserve & Surplus
777
845
861
870
957
2,108
Share Capital
16
18
18
18
18
21

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
239
-150
-1
75
-80
-24
79
Investing Activities
-158
-262
-260
-102
-99
-191
-536
Operating Activities
129
116
-36
105
219
263
314
Financing Activities
268
-4
296
72
-201
-95
301

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
39.64 %
35.24 %
35.24 %
35.17 %
35.15 %
34.93 %
FIIs
0.00 %
7.64 %
11.72 %
12.36 %
14.58 %
22.49 %
DIIs
0.00 %
5.61 %
11.95 %
13.26 %
21.64 %
29.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.68 %
8.88 %
7.69 %
6.56 %
7.90 %
Others
60.36 %
32.84 %
32.22 %
31.52 %
22.07 %
4.74 %
No of Share Holders
70
5,72,970
82
1,40,677
1,26,380
1,19,704

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 695.75 694.80
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 May 2025 717.70 713.35
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 815.20 792.85
11 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Sept 2025 791.55 861.70
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 892.85 923.20

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS3 days ago
Intimation For Order Dated 19Th November 2025 Issued By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi U/S 107 (11) Of The Karnataka Goods And Services Tax Act 2017 And The Central Goods And Services Tax Act 2017.6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Intimation Of Order Dated 12Th November 2025 Passed By The Assistant Commissioner Central Tax Division-II (Pimpri) Pune-I Commissionerate U/S 74 Of The CGST Act 2017.Nov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended On 30 September 2025Nov 06, 2025
Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended On 30 September 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2025
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 30 September 2025.Oct 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 17, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Oct 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Closure of Trading WindowSep 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 11, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 11, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 03, 2025
Corrigendum To The Notice Of The 26Th Annual General Meeting.Sep 03, 2025
Company -UpdatesSep 03, 2025
Company-UpdatesSep 02, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 28, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Reg. 34 (1) Annual Report.Aug 18, 2025
Notice Of 26Th Annual General Meeting Of The Members Of Sai Life Sciences Limited To Be Held On Thursday 11Th September 2025 At 10.30 A.M. (IST)Aug 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 18, 2025
Announcement under Regulation 30 (LODR)-Credit RatingAug 14, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 08, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 08, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal Business Cycle Fund Direct-Growth
1.71%
400000
1.71%
1.71%
HSBC Aggressive Hybrid Fund Direct-Growth
0.59%
349509
0.56%
0.57%
Edelweiss Balanced Advantage Fund Direct-Growth
0.00%
-177000
-0.12%
-0.11%
Union Midcap Fund Direct - Growth
0.92%
163106
0.92%
0.92%
Invesco India Multicap Fund Direct-Growth
2.44%
143820
0.37%
0.61%
Tata India Pharma & Healthcare Fund Direct-Growth
2.09%
138490
1.01%
1.07%
Union Innovation & Opportunities Fund Direct - Growth
0.97%
119396
0.97%
0.97%
Invesco India Mid Cap Fund Direct-Growth
3.30%
116840
0.03%
-0.01%
Invesco India Business Cycle Fund Direct-Growth
5.03%
102199
0.82%
0.37%
Union Large & Midcap Fund Direct - Growth
0.93%
95989
0.93%
0.93%
DSP Healthcare Fund Direct - Growth
5.23%
89231
0.46%
0.71%
Invesco India Manufacturing Fund Direct-Growth
1.69%
80435
1.03%
1.69%
Axis Innovation Fund Direct-Growth
1.78%
66103
0.56%
0.60%
Invesco India Flexi Cap Fund Direct - Growth
2.58%
54994
0.05%
0.65%
TRUSTMF Flexi Cap Fund Direct - Growth
0.00%
-51682
-0.40%
-0.43%
DSP Multicap Fund Direct - Growth
1.03%
49550
0.19%
0.20%
Bandhan Innovation Fund Direct-Growth
1.39%
49536
0.23%
0.84%
ITI Small Cap Fund Direct-Growth
1.04%
37834
0.13%
0.21%
Union Small Cap Fund Direct-Growth
1.16%
31000
0.18%
0.81%
Nippon India Value Fund Direct-Growth
0.00%
-27738
-0.03%
-0.03%
Bandhan Small Cap Fund Direct-Growth
0.23%
-27000
-0.02%
-0.07%
Kotak Healthcare Fund Direct - Growth
2.77%
25000
0.54%
0.65%
ITI Multi Cap Fund Direct - Growth
1.05%
15013
0.12%
0.16%
Edelweiss Recently Listed IPO Fund Direct-Growth
4.22%
15000
0.34%
0.38%
ITI Pharma and Healthcare Fund Direct - Growth
1.53%
-6638
-0.20%
-0.12%

Technical Indicators

RSI(14)
Neutral
47.59
ATR(14)
Volatile
25.69
STOCH(9,6)
Neutral
28.07
STOCH RSI(14)
Neutral
20.56
MACD(12,26)
Bearish
-2.83
ADX(14)
Weak Trend
17.45
UO(9)
Bearish
47.18
ROC(12)
Downtrend But Slowing Down
-0.09
WillR(14)
Neutral
-65.93